Cargando…

Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy

BACKGROUND: Home based oral immunotherapy (OIT) for food allergy has often been used for young children in Japan, the majority of whom are believed to outgrow the allergy by the school age, therefore the true efficacy of the therapy has been controversial. The aim of this study was to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudo, Kyoko, Taniuchi, Shoichiro, Takahashi, Masaya, Soejima, Kazuhiko, Hatano, Yasuko, Nakano, Keiji, Shimo, Tomohiko, Koshino, Hayato, Kaneko, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938305/
https://www.ncbi.nlm.nih.gov/pubmed/24572125
http://dx.doi.org/10.1186/1710-1492-10-11
_version_ 1782305579067244544
author Sudo, Kyoko
Taniuchi, Shoichiro
Takahashi, Masaya
Soejima, Kazuhiko
Hatano, Yasuko
Nakano, Keiji
Shimo, Tomohiko
Koshino, Hayato
Kaneko, Kazunari
author_facet Sudo, Kyoko
Taniuchi, Shoichiro
Takahashi, Masaya
Soejima, Kazuhiko
Hatano, Yasuko
Nakano, Keiji
Shimo, Tomohiko
Koshino, Hayato
Kaneko, Kazunari
author_sort Sudo, Kyoko
collection PubMed
description BACKGROUND: Home based oral immunotherapy (OIT) for food allergy has often been used for young children in Japan, the majority of whom are believed to outgrow the allergy by the school age, therefore the true efficacy of the therapy has been controversial. The aim of this study was to evaluate the efficacy and safety of a newly developed slow- type home-based oral immunotherapy (OIT) regimen in children with hen’s egg (HE) allergy, who had low likelihood of outgrowing the allergy, with treatment involving only elimination diet. METHOD: We retrospectively reviewed the medical records of 43 children with egg allergy (30 males; median age 6) who fulfilled Burks et al.’s criteria of being unlikely to outgrow the allergy. Thirty children who agreed to start OIT were assigned to the treatment group, and 13 who did not want to participate immediately were assigned to the untreated group; the patients underwent an elimination diet for 1 year, during which they were monitored. The OIT regimen involved the intake of the maximum tolerated dose 2 to 3 times a week at home, with initial dose introduction followed by dose build-ups with medical supervision. We statistically evaluated the rate of children who changed their threshold up to 32 g of egg – defined as, oral tolerance induction– in both the groups for 1 year and in the OIT group for 2 years, as well as the rate of children who fulfilled Savage et al.’s criteria of clinical tolerance after reaching the abovementioned remission stage. RESULTS: The rate of children who achieved oral tolerance induction to 32 g of egg after 1 year in the OIT group (9/30) was significantly higher than that in the untreated group (0/13). The total rate within the OIT group was significantly increased from 9/30 at 1 year to 17/30 at two years without any severe adverse reaction; of the above 17 children, we followed 14 children, and noted that 11 of these were able to obtain clinical tolerance. CONCLUSION: The home-based OIT with an intermittent loading protocol was very safe and effective in children with a low likelihood of outgrowing egg allergy.
format Online
Article
Text
id pubmed-3938305
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39383052014-03-01 Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy Sudo, Kyoko Taniuchi, Shoichiro Takahashi, Masaya Soejima, Kazuhiko Hatano, Yasuko Nakano, Keiji Shimo, Tomohiko Koshino, Hayato Kaneko, Kazunari Allergy Asthma Clin Immunol Research BACKGROUND: Home based oral immunotherapy (OIT) for food allergy has often been used for young children in Japan, the majority of whom are believed to outgrow the allergy by the school age, therefore the true efficacy of the therapy has been controversial. The aim of this study was to evaluate the efficacy and safety of a newly developed slow- type home-based oral immunotherapy (OIT) regimen in children with hen’s egg (HE) allergy, who had low likelihood of outgrowing the allergy, with treatment involving only elimination diet. METHOD: We retrospectively reviewed the medical records of 43 children with egg allergy (30 males; median age 6) who fulfilled Burks et al.’s criteria of being unlikely to outgrow the allergy. Thirty children who agreed to start OIT were assigned to the treatment group, and 13 who did not want to participate immediately were assigned to the untreated group; the patients underwent an elimination diet for 1 year, during which they were monitored. The OIT regimen involved the intake of the maximum tolerated dose 2 to 3 times a week at home, with initial dose introduction followed by dose build-ups with medical supervision. We statistically evaluated the rate of children who changed their threshold up to 32 g of egg – defined as, oral tolerance induction– in both the groups for 1 year and in the OIT group for 2 years, as well as the rate of children who fulfilled Savage et al.’s criteria of clinical tolerance after reaching the abovementioned remission stage. RESULTS: The rate of children who achieved oral tolerance induction to 32 g of egg after 1 year in the OIT group (9/30) was significantly higher than that in the untreated group (0/13). The total rate within the OIT group was significantly increased from 9/30 at 1 year to 17/30 at two years without any severe adverse reaction; of the above 17 children, we followed 14 children, and noted that 11 of these were able to obtain clinical tolerance. CONCLUSION: The home-based OIT with an intermittent loading protocol was very safe and effective in children with a low likelihood of outgrowing egg allergy. BioMed Central 2014-02-26 /pmc/articles/PMC3938305/ /pubmed/24572125 http://dx.doi.org/10.1186/1710-1492-10-11 Text en Copyright © 2014 Sudo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sudo, Kyoko
Taniuchi, Shoichiro
Takahashi, Masaya
Soejima, Kazuhiko
Hatano, Yasuko
Nakano, Keiji
Shimo, Tomohiko
Koshino, Hayato
Kaneko, Kazunari
Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy
title Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy
title_full Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy
title_fullStr Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy
title_full_unstemmed Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy
title_short Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy
title_sort home-based oral immunotherapy (oit) with an intermittent loading protocol in children unlikely to outgrow egg allergy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938305/
https://www.ncbi.nlm.nih.gov/pubmed/24572125
http://dx.doi.org/10.1186/1710-1492-10-11
work_keys_str_mv AT sudokyoko homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT taniuchishoichiro homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT takahashimasaya homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT soejimakazuhiko homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT hatanoyasuko homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT nakanokeiji homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT shimotomohiko homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT koshinohayato homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy
AT kanekokazunari homebasedoralimmunotherapyoitwithanintermittentloadingprotocolinchildrenunlikelytooutgroweggallergy